1,880
Views
3
CrossRef citations to date
0
Altmetric
Review

Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis

, , , , , , , , , , & show all
Article: 2194986 | Received 14 Aug 2022, Accepted 20 Mar 2023, Published online: 08 Apr 2023

References

  • Arroyo, R. and Alderete, J., 1995. Two Trichomonas vaginalis surface proteinases bind to host epithelial cells and are related to levels of cytoadherence and cytotoxicity. Archives of Medical Research, 26 (3), 279–285.
  • Barrington, J., et al., 1997. Anaerobic (bacterial) vaginosis and premalignant disease of the cervix. Journal of Obstetrics and Gynaecology, 17 (4), 383–385.
  • Belfort, I.K.P., et al., 2021. Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil. BMC Women’s Health, 21 (1), 1–8.
  • Costa, R.F., et al., 2005. Trichomonas vaginalis perturbs the junctional complex in epithelial cells. Cell Research, 15 (9), 704–716.
  • Depuydt, C.E., et al., 2010. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in Flanders. Gynecologic and Obstetric Investigation, 70 (4), 273–280.
  • Discacciati, M.G., et al., 2006. Is bacterial vaginosis associated with squamous intraepithelial lesion of the uterine cervix? Diagnostic Cytopathology, 34 (5), 323–325.
  • Donders, G.G., et al., 2013. Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women. PLOS One, 8 (12), e86266.
  • Ferré, V.M., et al., 2019. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey. Clinical Microbiology and Infection, 25 (12), e1561.
  • Ghosh, I., et al., 2012. Prevalence of human papillomavirus and co-existent sexually transmitted infections among female sex workers, men having sex with men and injectable drug abusers from eastern India. Asian Pacific Journal of Cancer Prevention, 13 (3), 799–802.
  • Hirt, R.P. and Sherrard, J., 2015. Trichomonas vaginalis origins, molecular pathobiology and clinical considerations. Current Opinion in Infectious Diseases, 28 (1), 72–79.
  • Hirth, J., 2019. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Human Vaccines & Immunotherapeutics, 15 (1), 146–155.
  • Hu, S.Y., et al., 2021. Association between common vaginal infections and cervical non-human papillomavirus (HPV) 16/18 infection in HPV-vaccinated women. The Journal of Infectious Diseases, 223 (3), 445–451.
  • Jary, A., et al., 2021. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali. International Journal of Infectious Diseases, 108, 610–616.
  • Lazenby, G.B., et al., 2014. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clinical Therapeutics, 36 (1), 38–45.
  • Lin, W.C., et al., 2015. The pathogenesis of human cervical epithelium cells induced by interacting with Trichomonas vaginalis. PLOS One, 10 (4), e0124087.
  • Liu, J., et al., 2016. Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China. Archives of Gynecology and Obstetrics, 293 (3), 595–602.
  • Lockhart, A., et al., 2019. Prevalence and risk factors of Trichomonas vaginalis among female sexual Workers in Nairobi, Kenya. Sexually Transmitted Diseases, 46 (7), 458–464.
  • Lsche, M., et al., 2021. HPV and other microbiota; who’s good and who’s bad: effects of the microbial environment on the development of cervical cancer—a non-systematic review. Cells, 10 (3), 714.
  • Mabaso, N. and Abbai, N.S., 2021. A review on Trichomonas vaginalis infections in women from Africa. Southern African Journal of Infectious Diseases, 36 (1), 254.
  • Masha, S.C., et al., 2019. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sexually Transmitted Infections, 95 (1), 36–42.
  • Mendoza, L., et al., 2013. Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infectious Diseases, 13 (1), 1–8.
  • Murta, E.F.C., et al., 2000. Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears. Sao Paulo Medical Journal, 118 (4), 105–108.
  • Noël, J.C., et al., 2010. High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology. Archives of Gynecology and Obstetrics, 282 (5), 503–505.
  • Provenzano, D. and Alderete, J., 1995. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infection and Immunity, 63 (9), 3388–3395.
  • Raffone, A., et al., 2021. Gardnerella vaginalis and Trichomonas vaginalis infections as risk factors for persistence and progression of low-grade precancerous cervical lesions in HIV-1 positive women. Pathology-Research and Practice, 219, 153349.
  • Rodriguez-Cerdeira, C., Sanchez-Blanco, E. and Alba, A., 2012. Evaluation of association between vaginal infections and high-risk human papillomavirus types in female sex workers in Spain. International Scholarly Research Notices, 2012, e240190.
  • Rowley, J., et al., 2019. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 97, 548–562.
  • Rughooputh, S. and Greenwell, P., 2005. Trichomonas vaginalis: paradigm of a successful sexually transmitted organism. British Journal of Biomedical Science, 62 (4), 193–200.
  • Schwebke, J.R. and Burgess, D., 2004. Trichomoniasis. Clinical Microbiology Reviews, 17 (4), 794–803.
  • Siegel, R.L., Miller, K.D. and Jemal, A., 2016. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66 (1), 7–30.
  • Spriggs, C.C. and Laimins, L.A., 2017. Human papillomavirus and the DNA damage response: exploiting host repair pathways for viral replication. Viruses, 9 (8), 232.
  • Taku, O., et al., 2021. Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa. PeerJ, 9, e10793.
  • Venegas, G., Boggiano, G. and Castro, E., 2011. Prevalence of bacterial vaginosis in Chilean sex workers. Revista Panamericana de Salud Publica, 30 (1), 46–50.
  • Wang, A., Wang, C.C. and Alderete, J.F., 1987. Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus. The Journal of Experimental Medicine, 166 (1), 142–150.
  • Wang, W., et al., 2020. Association between vaginal infections and the types and viral loads of human papillomavirus: a clinical study based on 4,449 cases of gynecologic outpatients. The Canadian Journal of Infectious Diseases & Medical Microbiology, 2020, e9172908.
  • Yuan, D., et al., 2021. Associations between bacterial vaginosis, candida vaginitis, Trichomonas vaginalis, and vaginal pathogenic community in Chinese women. American Journal of Translational Research, 13 (6), 7148.
  • Zhang, D., et al., 2017. Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China. PLOS One, 12 (5), e0178033.
  • Zhang, J., et al., 2022. Peptide-based nanovaccines in the treatment of cervical cancer: a review of recent advances. International Journal of Nanomedicine, 17, 869–900.
  • Zheng, M., et al., 2010. Association of human papillomavirus infection with other microbial pathogens in gynecology. Zhonghua Fu Chan Ke Za Zhi, 45 (6), 424–428.